DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 04 · Volume 02 · August 2013 DOI: 10.1055/s-003-25094

Review

Original Paper

130
Kienast, T.; Schlagenhauf, F.; Rapp, M. A.; Wrase, J.; Daig, I.; Buchholz, H.-G.; Smolka, M. N.; Gründer, G.; Kumakura, Y.; Cumming, P.; Charlet, K.; Bartenstein, P.; Hariri, A. R.; Heinz, A.: Dopamine-Modulated Aversive Emotion Processing Fails in Alcohol-Dependent Patients
137
Kim, J.-W.; Park, S.; Kim, B.-N.; Shin, M.-S.; Cho, S.-C.; Kim, J.-H.; Son, J.-W.; Shin, Y.-M.; Chung, U.-S.; Han, D.-H.: Parental Perceived Benefits of OROS-Methylphenidate Treatment for the Child with Attention-Deficit/Hyperactivity Disorder and for Parents Themselves
151
Hassan, A.; Teo, C.; Kennedy, J.L.; Ravindran, A.; De Luca, V.: Association of Ethnicity with Antipsychotic Dosage Using STRUCTURE Analysis
156
Háber, Á.; Rideg, O.; Osváth, P.; Fekete, S.; Szücs, F.; Fittler, A.; Kovács, G. L.; Miseta, A.; Botz, L.: Patients with Difficult-to-Treat Depression Do not Exhibit an Increased Frequency of CYP2D6 Allele Duplication

Letter